No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients

Rev Neurol (Paris). 2021 Mar;177(3):272-274. doi: 10.1016/j.neurol.2021.01.005. Epub 2021 Feb 11.

Abstract

Background: Governments around the world have imposed varied containment measures to curb the spread of the COVID-19 infection. The psychological impact could be highly negative in patients with neurologic condition like Parkinson's Disease (PD).

Methods: We prospectively evaluated symptoms of depression and anxiety in 50 (26 females; mean age at 60.4) non demented Moroccan PD patients, using Hospital Anxiety and Depression Scale (HADS), at the beginning and after 6 weeks of a full confinement.

Results: At the first evaluation, 28% of patients had depression while 32% had anxiety. After 6 weeks of confinement, some patients got worse and others got better scores but no significant statistical difference for both troubles was seen.

Conclusion: Our results show that there is no significant impact of 6 weeks of confinement on overall anxiety and depression scores. However, confinement could have an unexpected positive psychological impact on a significant number of PD patients.

Keywords: Anxiety; Confinement; Depression; Lockdown; Parkinson.

MeSH terms

  • Aged
  • Anxiety / epidemiology*
  • COVID-19 / epidemiology*
  • COVID-19 / psychology
  • Depression / epidemiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Morocco / epidemiology
  • Pandemics*
  • Parkinson Disease / complications
  • Parkinson Disease / epidemiology*
  • Parkinson Disease / psychology
  • Quarantine / psychology*
  • SARS-CoV-2 / physiology
  • Stress, Psychological / epidemiology
  • Stress, Psychological / psychology
  • Surveys and Questionnaires